Ownership
Private
Therapeutic Areas
OtherDermatologyRheumatology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Allograft (human tissue-derived)Synthetic bone graft (biphasic ceramic granules)Collagen-based scaffoldAmniotic tissue allograftBiologic barrier products

Ventris Medical General Information

Ventris Medical has received FDA 510(k) clearance for its Backpack® bone graft containment system and synthetic bone putty. The company’s products are designed to optimize cell proliferation and bone formation in orthopedic and spinal fusion surgeries. Their allograft fibers have demonstrated osteoinductive properties that promote stem cell differentiation into bone-forming cells. The company is recognized as an innovator in orthobiologics with a focus on both biologic and synthetic solutions.

Contact Information

Primary Industry
Surgical Medical Devices
Corporate Office
Newport Beach, California
United States

Drug Pipeline

Amplify Bone Graft Putty
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Ventris Medical's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Ventris Medical Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Ventris Medical's complete valuation and funding history, request access »

Ventris Medical Financial Metrics